Labome logo
home > Proteintech Group > Proteintech Group CD32 antibody
FCGR2A / CD32a
Proteintech Group
catalog: 15625-1-AP
domestic rabbit polyclonal
reactivity: human
application: western blot, ELISA, immunocytochemistry, flow cytometry
citations: 3

The FCGR2A / CD32a antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human FCGR2A / CD32a. This antibody recognizes human antigen. The FCGR2A / CD32a antibody has been validated for the following applications: FC, WB, ELISA analysis.
quantity: 150UL
price: 299 USD
to the supplier
FCGR2A / CD32a
Proteintech Group
catalog: 66529-1-Ig
mouse monoclonal (1D3F1)
reactivity: human
application: western blot, ELISA, immunohistochemistry, flow cytometry

The FCGR2A / CD32a antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human FCGR2A / CD32a. This antibody recognizes human antigen. The FCGR2A / CD32a antibody has been validated for the following applications: FC, IHC, WB, ELISA analysis.
quantity: 150UL
price: 299 USD
to the supplier
FCGR2A / CD32a
Proteintech Group
catalog: 27138-1-AP
domestic rabbit polyclonal
reactivity: human
application: western blot, ELISA

The FCGR2A / CD32a antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FCGR2A / CD32a. This antibody recognizes human antigen. The FCGR2A / CD32a antibody has been validated for the following applications: WB, ELISA analysis.
quantity: 150UL
price: 299 USD
to the supplier
FCGR2A / CD32a
Proteintech Group
catalog: CL488-66529
mouse monoclonal (1D3F1)
reactivity: human
conjugate: CoraLite488
application: ELISA, immunocytochemistry, flow cytometry

The FCGR2A / CD32a antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human FCGR2A / CD32a. This antibody recognizes human antigen. The FCGR2A / CD32a antibody has been validated for the following applications: FC, IF, ELISA analysis. This antibody is coralite488-conjugated.
quantity: 100UL
price: 299 USD
to the supplier
 
Labome.com © 2020 All Rights Reserved
last updated:2020-11-07